The Skin Health Institute is looking for individuals with moderate to severe eczema (atopic dermatitis) to participate in a new clinical trial using a treatment via injection.

The study runs over a 40-week period and includes up to 11 on-site clinic appointments. If you have been diagnosed with moderate to severe eczema for greater than 6 months with at least 10% of your body surface area effected and you have also had an inadequate response to topical corticosteroids, you may be eligible. There is no cost to participate, and study-related expenses will be reimbursed.